Intranasal immunization with live attenuated influenza vaccine plus chitosan as an adjuvant protects mice against homologous and heterologous virus challenge.
about
Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza.Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine.Chitosan-based vaccine adjuvants: incomplete characterization complicates preclinical and clinical evaluation.Use of chimeric influenza viruses as a novel internal control for diagnostic rRT-PCR assays.Mucosal polyinosinic-polycytidylic acid improves protection elicited by replicating influenza vaccines via enhanced dendritic cell function and T cell immunity.
P2860
Intranasal immunization with live attenuated influenza vaccine plus chitosan as an adjuvant protects mice against homologous and heterologous virus challenge.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Intranasal immunization with l ...... heterologous virus challenge.
@en
Intranasal immunization with l ...... heterologous virus challenge.
@nl
type
label
Intranasal immunization with l ...... heterologous virus challenge.
@en
Intranasal immunization with l ...... heterologous virus challenge.
@nl
prefLabel
Intranasal immunization with l ...... heterologous virus challenge.
@en
Intranasal immunization with l ...... heterologous virus challenge.
@nl
P2093
P2860
P1433
P1476
Intranasal immunization with l ...... heterologous virus challenge.
@en
P2093
Chaoyang Dai
Hanzhong Wang
Wenjie Zhang
Xueliang Wang
P2860
P2888
P304
P356
10.1007/S00705-012-1318-7
P577
2012-05-04T00:00:00Z
P6179
1019490329